Evidence map›Paper›PMID 27894319›Full record

ArticleJournal of experimental & clinical cancer research : CR2016

Erratum to: Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.

Andrea Prodosmo, Amelia Buffone, Manlio Mattioni, Agnese Barnabei, Agnese Persichetti, Aurora De Leo, Marialuisa Appetecchia, Arianna Nicolussi, Anna Coppa, Salvatore Sciacchitano and 12 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Andrea ProdosmoUnit of Cellular Networks and Molecular Therapeutic Targets, Department of Research, Advanced Diagnostic, and Technological Innovation, Regina Elena National Cancer Institute - IRCCS, Via Elio Chianesi 53, 00144, Rome, Italy.
Amelia BuffoneDepartment of Molecular Medicine, University La Sapienza, Rome, Italy.
Manlio MattioniUnit of Cellular Networks and Molecular Therapeutic Targets, Department of Research, Advanced Diagnostic, and Technological Innovation, Regina Elena National Cancer Institute - IRCCS, Via Elio Chianesi 53, 00144, Rome, Italy.
Agnese BarnabeiEndocrinology Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Agnese PersichettiEndocrinology Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Aurora De LeoEndocrinology Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Marialuisa AppetecchiaEndocrinology Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Arianna NicolussiDepartment of Experimental Medicine, Sapienza University of Rome, Policlinico Umberto I, Viale Regina Elena, 32400161, Rome, Italy.
Anna CoppaDepartment of Experimental Medicine, Sapienza University of Rome, Policlinico Umberto I, Viale Regina Elena, 32400161, Rome, Italy.
Salvatore SciacchitanoDepartment of Clinical and Molecular Medicine, University La Sapienza, Laboratorio di Ricerca Biomedica, Fondazione Università Niccolò Cusano per la Ricerca Medico Scientifica, Rome, Italy.
Carolina GiordanoRadiotherapy Unit, Department of Research, Advanced Diagnostic, and Technological Innovation, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Paola PinnaròRadiotherapy Unit, Department of Research, Advanced Diagnostic, and Technological Innovation, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Giuseppe SanguinetiRadiotherapy Unit, Department of Research, Advanced Diagnostic, and Technological Innovation, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Lidia StrigariMedical Physics Unit, Department of Research, Advanced Diagnostic, and Technological Innovation, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Gabriele AlessandriniToracic Surgery Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Francesco FaccioloToracic Surgery Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Maurizio CosimelliHepato-pancreato-biliary Surgery Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Gian Luca GraziHepato-pancreato-biliary Surgery Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Giacomo CorradoGynecological Oncology Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Enrico VizzaGynecological Oncology Unit, Department of Clinical and Experimental Oncology, Regina Elena National Cancer Institute - IRCCS, Rome, Italy.
Giuseppe GianniniIstituto Pasteur-Fondazione Cenci Bolognetti, Department of Molecular Medicine, University La Sapienza, Rome, Italy. giuseppe.giannini@uniroma1.it.
Silvia SodduUnit of Cellular Networks and Molecular Therapeutic Targets, Department of Research, Advanced Diagnostic, and Technological Innovation, Regina Elena National Cancer Institute - IRCCS, Via Elio Chianesi 53, 00144, Rome, Italy. silvia.soddu@ifo.gov.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27894319
PMCPMC5127086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.